Genetic test analysis company has cracked the code

A key pivot from end users to health insurance plans opened a lucrative growth phase for the St. Petersburg firm. Can it convince its clients to stick with outsourcing?

Mark Wemple. David Nixon, an early investor in Informed DNA, is also the CEO.
Mark Wemple. David Nixon, an early investor in Informed DNA, is also the CEO.
  • Strategies
  • Share

Rising demand for clinical genetic testing — brought on by advances in what’s known as precision or personalized medicine, which tailors treatments to suit a person’s unique gene code — has created a niche that St. Petersburg-based InformedDNA is ready to fill.

 

Continue reading your article
with a Business Observer subscription.
What's included:
  • ✓ Unlimited digital access to BusinessObserverFL.com
  • ✓ E-Newspaper app, digital replica of print edition
  • ✓ Mailed print newspaper every Friday (optional)
  • ✓ Newsletter of daily business news
Subscribe

Already subscribed? Sign in.

Latest News

  • March 16, 2026
St. Pete-Clearwater International Airport names new director
  • March 15, 2026
Two Tampa Bay medical buildings sold for nearly $13M
  • March 13, 2026
IncredibleBank opening new branch in Cape Coral
  • March 13, 2026
231-unit apartment complex to start construction in Manatee County

Sponsored Content